Vontobel Holding’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,000
Closed -$560K 1160
2022
Q1
$560K Buy
+20,000
New +$548K ﹤0.01% 760

Vontobel Holding's XENT Position: Q2 2022 in Review

Vontobel Holding sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 20,000 shares — an estimated $560K sold.

Vontobel Holding first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $560K in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Vontobel Holding reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Vontobel Holding sold 20,000 Intersect ENT, Inc shares in Q2 2022, an estimated $560K.
  • Vontobel Holding first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
  • Vontobel Holding's Intersect ENT, Inc position peaked at $560K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Vontobel Holding's 13F filing for Q2 2022, filed 27 Jul 2022.